Skip to main content

AI Bias Analysis

4 models · Takes ~15 seconds

MedPage Today

Real-World Registry Study Shows Alzheimer's Drug Safety Outcomes

Real-World Registry Study Shows Alzheimer's Drug Safety Outcomes
ShareXFacebook

(MedPage Today) -- The first interim safety results from a multicenter, safety surveillance study of Alzheimer's disease patients treated with lecanemab (Leqembi) in real-world clinical practice were consistent with the known safety profile of...

M

Source

MedPage Today

Read full article at MedPage Today

Opens original article in a new tab

Advertisement

Related Health Stories

Advertisement